4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-16-154212
Chief Executive Officer sold 7,200 shares at an average $17.93 ($129,060)
From the SEC's structured data for this filing
Trades in this filing
Ciechanover Isaac E. · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-12-06 | Sale : show line 1 in the form | −3,600 | $18.55 | $66,780 | 381,378 | I |
| 2016-12-07 | Sale : show line 2 in the form | −3,600 | $17.30 | $62,280 | 377,778 | I |
| Open-market sales · 7,200 sh · avg $17.93 · $129,060 | ||||||
Loading xslF345X03/doc4.xml…